AutifonyLtd @AutifonyLtd
Autifony Therapeutic  @AutifonyLtd
Autifony reports positive results in Phase Ib trial with AUT00206, its novel Kv3 ion channel modulator, please take… 
Autifony Therapeutic  @AutifonyLtd
Autifony Therapeutics achieves first milestone in agreement with Boehringer Ingelheim for a novel therapeutic appro… 
Autifony Therapeutic  @AutifonyLtd
Autifony is currently recruiting a Junior Medicinal Chemist, the position will be based in our lab in Stevenage, fo… 

Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image